big mover upCOYAmassive
Coya Therapeutics, Inc. (COYA) Surges 5.3% on Heavy Volume
Coya Therapeutics, Inc. (NASDAQ:COYA) surged 5.3% in today's trading, closing at $4.92.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Coya Therapeutics, Inc. (NASDAQ:COYA) surged 5.3% in today's trading, closing at $4.92.
Read moreP (NASDAQ:P) is scheduled to report its Q2 earnings results on August 19, 2026 after market close.
Read moreRoot, Inc. (NASDAQ:ROOT) surged 5.3% in today's trading, closing at $52.35.
Read moreGD Culture Group Limited (NASDAQ:GDC) surged 5.3% in today's trading, closing at $1.90.
Read moreEXYN (NASDAQ:EXYN) is scheduled to report its Q2 earnings results on August 19, 2026 after market close.
Read moreGeneral Enterprise Ventures, Inc. (AMEX:CITR) surged 5.2% in today's trading, closing at $6.03.
Read moreEROK (NASDAQ:EROK) is scheduled to report its Q2 earnings results on August 19, 2026 after market close.
Read moreAccendra Health, Inc. (NYSE:ACH) surged 5.1% in today's trading, closing at $1.12.
Read moreBXDC (NASDAQ:BXDC) is scheduled to report its Q2 earnings results on August 19, 2026 after market close.
Read moreCellebrite DI Ltd. (NASDAQ:CLBT) surged 5.1% in today's trading, closing at $10.97.
Read moreCalumet, Inc. (NASDAQ:CLMT) surged 5.1% in today's trading, closing at $50.82.
Read moreProShares UltraPro Short QQQ (NASDAQ:SQQQ) surged 5.0% in today's trading, closing at $38.25.
Read moreCBRS (NASDAQ:CBRS) is scheduled to report its Q2 earnings results on August 19, 2026 after market close.
Read moreBTIG reiterated its Buy rating on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) on August 18, 2026.
Read moreChardan Capital analysts initiated coverage on Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) with a rating of Buy on August 18, 2026.
Read moreTD Cowen reiterated its Hold rating on J.Jill, Inc. (NYSE:JILL) on August 18, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Pyxis Oncology, Inc.
Read moreJP Morgan reiterated its Overweight rating on Evolent Health, Inc. (NYSE:EVH) on August 18, 2026.
Read moreMizuho reiterated its Outperform rating on Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) on August 18, 2026.
Read moreBTIG reiterated its Buy rating on CeriBell, Inc. Common Stock (NASDAQ:CBLL) on August 18, 2026.
Read more